The North America Thrombosis And Hemostasis Biomarkers Market would witness market growth of 4.4% CAGR during the forecast period (2023-2030).
Hemostasis and thrombosis biomarkers are a heterogeneous range of biological molecules, cells, or characteristics from laboratory assays that assess hemostatic processes. Many of these indicators are well-characterized criteria with little logistical and financial costs for therapeutic use. Hemostasis, which means keeping blood inside a broken blood vessel, is a biological process to stop and prevent bleeding, which is the first phase of wound healing. Coagulation is involved in this, which turns blood from a liquid into a gel. A blood clot, or thrombus, forming inside a blood vessel is called thrombosis.
It hinders the circulatory system's ability to function correctly by stopping blood flow. The epidemiology of thrombosis differs depending on whether it occurs in the venous or arterial system, whether it is triggered or not, and whether it is the first or subsequent occurrence.
The high prevalence of lung cancer in the region leads to more pulmonary embolism (PE) cases. According to the CDC, the US had 654,620 men and women with previous lung cancer diagnoses as of January 1, 2022, many of whom were coping with metastatic disease. The advanced average age of diagnosis (71 years) is reflected by the fact that about 80% of these people were 65 or older. Due to the poor survival rate, over half (55%) of lung cancer survivors were diagnosed within the previous five years. Hence, the regional market will have numerous growth opportunities in the coming years because of all these elements.
The US market dominated the North America Thrombosis And Hemostasis Biomarkers Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,824.3 million by 2030. The Canada market is poised to grow at a CAGR of 6.7% during (2023 - 2030). Additionally, The Mexico market would witness a CAGR of 5.8% during (2023 - 2030).
Based on Product, the market is segmented into Reagents & Consumables, and Analyzers. Based on Application, the market is segmented into Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Disseminated Intravascular Coagulation (DIC) & Others. Based on End-use, the market is segmented into Diagnostic Centers, Hospitals & Clinics, and Academic & Research Institutes and Others. Based on Location, the market is segmented into Clinical Laboratory Tests, and Point-of-Care Tests. Based on Type, the market is segmented into Post-Thrombin (PT), Activated Partial Thromboplastin Time (APTT) Test, D-Dimer, Anti-Thrombin III, Plasminogen & Fibrinogen, Soluble Fibrin, Selectins, Factor VIII, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Thrombosis And Hemostasis Biomarkers Market is Projected to reach USD 7.4 Billion by 2030, at a CAGR of 5.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Siemens Healthineers AG (Siemens AG), Abbott Laboratories, BioMérieux S.A., Horiba Ltd., QuidelOrtho Corporation, Werfen, S.A., Diazyme Laboratories, Inc. (General Atomics) and BioMedica Diagnostics Inc. (Scotia Investments Family of Companies).
Scope of the Study
Market Segments Covered in the Report:
By Product
- Reagents & Consumables
- Analyzers
By Application
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Disseminated Intravascular Coagulation (DIC) & Others
By End-Use
- Diagnostic Centers
- Hospitals & Clinics
- Academic & Research Institutes and Others
By Location
- Clinical Laboratory Tests
- Point-of-Care Tests
By Type
- Post-Thrombin (PT)
- Activated Partial Thromboplastin Time (APTT) Test
- D-Dimer
- Anti-Thrombin III
- Plasminogen & Fibrinogen
- Soluble Fibrin
- Selectins
- Factor VIII
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers AG (Siemens AG)
- Abbott Laboratories
- BioMérieux S.A.
- Horiba Ltd.
- QuidelOrtho Corporation
- Werfen, S.A.
- Diazyme Laboratories, Inc. (General Atomics)
- BioMedica Diagnostics Inc. (Scotia Investments Family of Companies)
TABLE 1 North America Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
TABLE 2 North America Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
TABLE 3 North America Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
TABLE 4 North America Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
TABLE 5 North America Reagents & Consumables Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Reagents & Consumables Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
TABLE 10 North America Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
TABLE 11 North America Deep Vein Thrombosis (DVT) Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Deep Vein Thrombosis (DVT) Market by Country, 2023 - 2030, USD Million
TABLE 13 North America Pulmonary Embolism (PE) Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Pulmonary Embolism (PE) Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Disseminated Intravascular Coagulation (DIC) & Others Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Disseminated Intravascular Coagulation (DIC) & Others Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
TABLE 18 North America Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
TABLE 19 North America Diagnostic Centers Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Diagnostic Centers Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Academic & Research Institutes and Others Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Academic & Research Institutes and Others Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
TABLE 26 North America Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
TABLE 27 North America Clinical Laboratory Tests Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Clinical Laboratory Tests Market by Country, 2023 - 2030, USD Million
TABLE 29 North America Point-of-Care Tests Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Point-of-Care Tests Market by Country, 2023 - 2030, USD Million
TABLE 31 North America Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
TABLE 32 North America Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
TABLE 33 North America Post-Thrombin (PT) Market by Country, 2019 - 2022, USD Million
TABLE 34 North America Post-Thrombin (PT) Market by Country, 2023 - 2030, USD Million
TABLE 35 North America Activated Partial Thromboplastin Time (APTT) Test Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Activated Partial Thromboplastin Time (APTT) Test Market by Country, 2023 - 2030, USD Million
TABLE 37 North America D-Dimer Market by Country, 2019 - 2022, USD Million
TABLE 38 North America D-Dimer Market by Country, 2023 - 2030, USD Million
TABLE 39 North America Anti-Thrombin III Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Anti-Thrombin III Market by Country, 2023 - 2030, USD Million
TABLE 41 North America Plasminogen & Fibrinogen Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Plasminogen & Fibrinogen Market by Country, 2023 - 2030, USD Million
TABLE 43 North America Soluble Fibrin Market by Country, 2019 - 2022, USD Million
TABLE 44 North America Soluble Fibrin Market by Country, 2023 - 2030, USD Million
TABLE 45 North America Selectins Market by Country, 2019 - 2022, USD Million
TABLE 46 North America Selectins Market by Country, 2023 - 2030, USD Million
TABLE 47 North America Factor VIII Market by Country, 2019 - 2022, USD Million
TABLE 48 North America Factor VIII Market by Country, 2023 - 2030, USD Million
TABLE 49 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 50 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 51 North America Thrombosis And Hemostasis Biomarkers Market by Country, 2019 - 2022, USD Million
TABLE 52 North America Thrombosis And Hemostasis Biomarkers Market by Country, 2023 - 2030, USD Million
TABLE 53 US Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
TABLE 54 US Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
TABLE 55 US Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
TABLE 56 US Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
TABLE 57 US Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
TABLE 58 US Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
TABLE 59 US Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
TABLE 60 US Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
TABLE 61 US Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
TABLE 62 US Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
TABLE 63 US Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
TABLE 64 US Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
TABLE 65 Canada Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
TABLE 66 Canada Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
TABLE 67 Canada Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
TABLE 68 Canada Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
TABLE 69 Canada Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
TABLE 70 Canada Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
TABLE 71 Canada Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
TABLE 72 Canada Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
TABLE 73 Canada Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
TABLE 74 Canada Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
TABLE 75 Canada Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
TABLE 76 Canada Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
TABLE 77 Mexico Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
TABLE 78 Mexico Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
TABLE 79 Mexico Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
TABLE 80 Mexico Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
TABLE 81 Mexico Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
TABLE 82 Mexico Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
TABLE 83 Mexico Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
TABLE 84 Mexico Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
TABLE 85 Mexico Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
TABLE 86 Mexico Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
TABLE 87 Mexico Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
TABLE 88 Mexico Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
TABLE 89 Rest of North America Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
TABLE 90 Rest of North America Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
TABLE 91 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
TABLE 92 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
TABLE 93 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
TABLE 94 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
TABLE 95 Rest of North America Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
TABLE 96 Rest of North America Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
TABLE 97 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
TABLE 98 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
TABLE 99 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
TABLE 100 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
TABLE 101 Key Information – Thermo Fisher Scientific, Inc.
TABLE 102 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 103 Key Information – Siemens Healthineers AG
TABLE 104 Key Information – Abbott Laboratories
TABLE 105 Key information – BioMérieux S.A.
TABLE 106 key Information – Horiba Ltd.
TABLE 107 key information – QuidelOrtho Corporation
TABLE 108 Key Information – Werfen, S.A.
TABLE 109 Key Information – Diazyme Laboratories, Inc.
TABLE 110 Key Information – BioMedica Diagnostics Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Thrombosis And Hemostasis Biomarkers Market share by Product, 2022
FIG 3 North America Thrombosis And Hemostasis Biomarkers Market share by Product, 2030
FIG 4 North America Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2030, USD Million
FIG 5 North America Thrombosis And Hemostasis Biomarkers Market share by Application, 2022
FIG 6 North America Thrombosis And Hemostasis Biomarkers Market share by Application, 2030
FIG 7 North America Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2030, USD Million
FIG 8 North America Thrombosis And Hemostasis Biomarkers Market share by End-use, 2022
FIG 9 North America Thrombosis And Hemostasis Biomarkers Market share by End-use, 2030
FIG 10 North America Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2030, USD Million
FIG 11 North America Thrombosis And Hemostasis Biomarkers Market share by Location, 2022
FIG 12 North America Thrombosis And Hemostasis Biomarkers Market share by Location, 2030
FIG 13 North America Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2030, USD Million
FIG 14 North America Thrombosis And Hemostasis Biomarkers Market share by Type, 2022
FIG 15 North America Thrombosis And Hemostasis Biomarkers Market share by Type, 2030
FIG 16 North America Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2030, USD Million
FIG 17 North America Thrombosis And Hemostasis Biomarkers Market share by Country, 2022
FIG 18 North America Thrombosis And Hemostasis Biomarkers Market share by Country, 2030
FIG 19 North America Thrombosis And Hemostasis Biomarkers Market by Country, 2019 - 2030, USD Million
FIG 20 Swot analysis: thermo fisher scientific, inc.
FIG 21 Swot analysis: Siemens AG
FIG 22 Swot analysis: Abbott laboratories